Uterine fibroids — benign smooth muscle tumors of the uterus — are the most common pelvic tumors in women, present in up to 70% of women by age 50. Most fibroids cause no fertility problems, but a significant subset — depending on size and location — can meaningfully impair ICI success rates. Knowing which fibroids matter and what to do about them is essential for ICI candidates with a known fibroid diagnosis.
Fibroid Classification and Fertility Impact by Location
Uterine fibroids are classified by their relationship to the uterine layers: submucosal fibroids protrude into the uterine cavity; intramural fibroids are contained within the myometrium; subserosal fibroids project from the outer uterine surface. This classification is not merely anatomical — it directly determines fertility impact. Submucosal fibroids have the most clearly established negative effect on fertility: a 2001 ASRM meta-analysis found that submucosal fibroids reduce pregnancy rates by approximately 50–70% in IVF and IUI cycles. Even small submucosal fibroids that distort the endometrial cavity impair implantation, and their removal (hysteroscopic myomectomy) consistently restores pregnancy rates toward baseline in controlled studies.
Intramural fibroids present a more complex picture. Large intramural fibroids (above 4–5 cm) or those that significantly distort the uterine cavity have documented negative effects on IVF pregnancy rates; however, intramural fibroids that do not encroach on the cavity appear to have minimal impact on fertility in most studies. Small-to-moderate intramural fibroids (under 4 cm, non-cavity-distorting) are generally not treated before ICI unless they are symptomatic (heavy bleeding, pain). Subserosal fibroids that do not encroach on the cavity have no established negative effect on fertility and are not treated before fertility treatment in the absence of other indications.
Diagnosing Fibroids and Assessing Their Significance
Uterine fibroids are most commonly detected incidentally on pelvic ultrasound performed for other indications, or through investigation of heavy menstrual bleeding, pelvic pain, or infertility. For ICI candidates, the relevant diagnostic questions are: Does the fibroid distort the endometrial cavity? What is its size and location? Are there signs of submucosal component? A standard transvaginal ultrasound can detect most significant fibroids but may miss small submucosal lesions or fail to characterize cavity distortion precisely.
Saline infusion sonography (SIS) is the most sensitive outpatient method for detecting submucosal component and cavity distortion — it has equivalent sensitivity to hysteroscopy for intrauterine lesion detection in most studies and is far less invasive. For ICI candidates with any fibroid on standard ultrasound, SIS is the recommended next step to characterize the fibroid’s relationship to the endometrial cavity. If SIS shows no cavity distortion, the fibroid is likely fertility-neutral and ICI can proceed. If SIS shows a submucosal component or significant cavity indentation, hysteroscopic evaluation and likely treatment is warranted before cycling.
Surgical Treatment Options and Their Impact
Hysteroscopic myomectomy — removal of submucosal fibroids through a hysteroscope inserted through the cervix without abdominal incision — is the most evidence-supported surgical intervention for fertility-impairing fibroids. Recovery is rapid (1–2 weeks), intrauterine adhesion formation is uncommon with experienced surgeons, and pregnancy rates post-procedure consistently improve in controlled studies. For FIGO type 0 (entirely intracavitary) and type 1 (less than 50% intramural) submucosal fibroids, hysteroscopic myomectomy is the standard of care.
Abdominal or laparoscopic myomectomy is indicated for intramural fibroids causing cavity distortion that cannot be accessed hysteroscopically, or for large fibroids significantly impairing uterine blood flow. Abdominal myomectomy carries higher procedural complexity, longer recovery (4–6 weeks), and intrauterine adhesion risks if the uterine cavity is entered during the procedure. The decision to proceed with myomectomy for fertility indications requires careful individualization — the benefits of fibroid removal must exceed the procedural risks of myomectomy (including scar formation, uterine weakness affecting future pregnancy, and adhesion risk) for the decision to be appropriate. This is a decision made in partnership with a reproductive surgeon with specific expertise in fibroid management.
When to Watch and Wait vs. When to Treat
The decision algorithm for fibroid management before ICI is relatively straightforward when organized by location and cavity involvement. Submucosal fibroids with cavity distortion: treat before ICI. Intramural fibroids above 4 cm with cavity distortion confirmed on SIS: discuss surgical management with an RE. Intramural fibroids under 4 cm without cavity distortion: proceed with ICI without fibroid treatment; reassess after three cycles if outcome is poor. Subserosal fibroids regardless of size: proceed with ICI without fibroid treatment. All fibroid decisions should factor in: patient age (urgency of proceeding immediately without surgical delay), surgical risk (particularly for complex multiple fibroids), and the patient’s symptom burden independent of fertility.
For ICI candidates with known fibroids who have not yet had SIS imaging, obtaining SIS before beginning cycles is the most rational approach — it either confirms the fibroid is fertility-neutral (and you proceed immediately) or identifies a treatable problem (and you treat before wasting cycles). The marginal cost of SIS ($300–$600) is small relative to the cost of multiple failed ICI cycles in the presence of an undiagnosed submucosal fibroid. The small time investment in imaging provides a level of protocol confidence that no amount of cycle optimization can substitute for.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: IntracervicalInsemination.org · MakeAmom.com
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.
